Three-quarters of the world’s annual emissions of greenhouse gases are now limited by national targets,…
Month: May 2015
Immunotherapy drug improves survival for common form of lung cancer
In a head-to-head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers found…
Contact lens wearers: Eyes may get more infections because their ‘microbiomes’ have changed
Using high-precision genetic tests to differentiate the thousands of bacteria that make up the human…
Possible new combination chemotherapy for patients with advanced prostate cancer
A role for combination therapy using two or more chemotherapy agents at the same time…
Risks of whole brain radiation therapy added to radiosurgery outweigh benefits for patients with limited brain metastases
Whole Brain Radiation Therapy (WBRT) is associated with significantly worse cognitive function than radiosurgery, and…
Immunotherapy combo increases progression-free survival in advanced melanoma patients
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab and ipilimumab…
Gene therapy, surgery could mean eight more months for sickest brain cancer patients
As the most malignant of primary brain cancers, glioblastomas are frustratingly difficult to treat. Surgery…
Mobile Maestro: Immersive sound reproduction system from several smart phones
Mobile Maestro enables users to enjoy a high-quality listening experience anytime and anywhere through the…
Combining targeted drug with chemotherapy offers longer life to b-cell cancer patients
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy…
Scale to stratify magnitude of clinical benefit of anticancer medicines
ESMO, the European Society for Medical Oncology, has announced the publication of the ESMO Magnitude…